| Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10269), 99-111, 2021 | 5277 | 2021 |
| Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B. 1.351 variant SA Madhi, V Baillie, CL Cutland, M Voysey, AL Koen, L Fairlie, ... New England Journal of Medicine 384 (20), 1885-1898, 2021 | 1370 | 2021 |
| Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four … M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10277), 881-891, 2021 | 1326 | 2021 |
| Efficacy of NVX-CoV2373 Covid-19 vaccine against the B. 1.351 variant V Shinde, S Bhikha, Z Hoosain, M Archary, Q Bhorat, L Fairlie, U Lalloo, ... New England Journal of Medicine 384 (20), 1899-1909, 2021 | 677 | 2021 |
| Dolutegravir plus two different prodrugs of tenofovir to treat HIV WDF Venter, M Moorhouse, S Sokhela, L Fairlie, N Mashabane, ... New England Journal of Medicine 381 (9), 803-815, 2019 | 569 | 2019 |
| COVID-19 in Africa: care and protection for frontline healthcare workers MF Chersich, G Gray, L Fairlie, Q Eichbaum, S Mayhew, B Allwood, ... Globalization and health 16, 1-6, 2020 | 496 | 2020 |
| Antiretroviral treatment, management challenges and outcomes in perinatally HIV‐infected adolescents AL Agwu, L Fairlie African Journal of Reproduction and Gynaecological Endoscopy 16 (1), 2013 | 252 | 2013 |
| Providing comprehensive health services for young key populations: needs, barriers and gaps S Delany‐Moretlwe, FM Cowan, J Busza, C Bolton‐Moore, K Kelley, ... Journal of the International AIDS Society 18, 19833, 2015 | 212 | 2015 |
| Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial … WDF Venter, S Sokhela, B Simmons, M Moorhouse, L Fairlie, ... The lancet HIV 7 (10), e666-e676, 2020 | 200 | 2020 |
| Treatment and outcomes in children with multidrug-resistant tuberculosis: a systematic review and individual patient data meta-analysis EP Harausz, AJ Garcia-Prats, S Law, HS Schaaf, T Kredo, JA Seddon, ... PLoS medicine 15 (7), e1002591, 2018 | 145 | 2018 |
| Oxford COVID Vaccine Trial Group Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in … M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... Lancet 397 (10269), 99-111, 2021 | 133 | 2021 |
| Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised … SA Madhi, AL Koen, A Izu, L Fairlie, CL Cutland, V Baillie, ... The Lancet HIV 8 (9), e568-e580, 2021 | 130 | 2021 |
| Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir … S Lockman, SS Brummel, L Ziemba, L Stranix-Chibanda, K McCarthy, ... The Lancet 397 (10281), 1276-1292, 2021 | 109 | 2021 |
| Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine against the B. 1.351 variant in South Africa SA Madhi, V Baillie, CL Cutland, M Voysey, AL Koen, L Fairlie, ... MedRxiv, 2021.02. 10.21251247, 2021 | 103 | 2021 |
| High prevalence of childhood multi-drug resistant tuberculosis in Johannesburg, South Africa: a cross sectional study L Fairlie, NC Beylis, G Reubenson, DP Moore, SA Madhi BMC infectious diseases 11, 1-9, 2011 | 101 | 2011 |
| Neuropsychological performance in African children with HIV enrolled in a multisite antiretroviral clinical trial MJ Boivin, L Barlow-Mosha, MC Chernoff, B Laughton, B Zimmer, C Joyce, ... Aids 32 (2), 189-204, 2018 | 80 | 2018 |
| Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study JM Baeten, T Palanee-Phillips, NM Mgodi, AJ Mayo, DW Szydlo, ... The lancet HIV 8 (2), e87-e95, 2021 | 79 | 2021 |
| Lopinavir exposure is insufficient in children given double doses of lopinavir/ritonavir during rifampicin-based treatment for tuberculosis H McIlleron, Y Ren, J Nuttall, L Fairlie, H Rabie, M Cotton, B Eley, ... Antiviral therapy 16 (3), 417-421, 2011 | 74 | 2011 |
| Mortality and losses to follow‐up among adolescents living with HIV in the Ie DEA global cohort collaboration A Kariminia, M Law, MA Davies, M Vinikoor, K Wools‐Kaloustian, V Leroy, ... Journal of the International AIDS Society 21 (12), e25215, 2018 | 64 | 2018 |
| Neurodevelopmental delay: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data AN Villagomez, FM Muñoz, RL Peterson, AM Colbert, M Gladstone, ... Vaccine 37 (52), 7623, 2019 | 60 | 2019 |
